Co-Diagnostics Inc. (CODX)
NASDAQ: CODXHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
CODX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $7.61M
- EPS (TTM)
- -$26.14
- Dividend yield
- None
- 52-week range
- 0.906 – 46.50
- Day range
- 1.08 – 1.15
- Volume / Avg
- 139.66K / 326.53K
- Beta
- —
- Shares outstanding
- 6.98M
52-week range
CODX stock today
Co-Diagnostics (CODX) closed at $1.09 on Oct 8, down 2.68% (-$0.03), versus the S&P 500's 0.47% decline. Trading was light, with 139.66K shares changing hands, about 43% of the average daily volume. At this level, CODX sits near the bottom of its 52-week range of $0.906 to $46.50: 97.7% below the high and 20.3% above the low.
Co-Diagnostics has posted a net loss over the last twelve months (EPS of -$26.14), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Co-Diagnostics
Company profileCo-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Dwight H. Egan
- Headquarters
- Salt Lake City, UT
- Employees
- 115
- IPO year
- 2026
- Website
- co-dx.com
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$4.00+266.97%
- Strong buy 1
- Buy 0
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
CODX news
All CODX newsCo-Diagnostics peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| WOKWORK Medical Technology Group LTD Class A | 1.52 | -1.94% | $6.79M | vs CODX |
| VNRXVolitionRX Limited | 0.2194 | -2.92% | $6.60M | vs CODX |
| BMRABiomerica Inc. | 1.89 | -0.53% | $8.69M | vs CODX |
| AMIXAutonomix Medical Inc. | 3.13 | -8.21% | $6.13M | vs CODX |
| TNONTenon Medical Inc. | 3.44 | -1.71% | $9.25M | vs CODX |
| NVNOenVVeno Medical Corporation | 8.18 | -2.68% | $5.68M | vs CODX |
| AEMDAethlon Medical Inc. | 6.01 | -0.99% | $9.64M | vs CODX |
| NMTCNeuroOne Medical Technologies Corporation | 1.08 | -2.70% | $9.83M | vs CODX |
Indexes, lists and sector
Appears in lists
Co-Diagnostics stock FAQ
What is Co-Diagnostics's stock price today?
CODX last traded at $1.09 as of Oct 8, 4:00 PM EDT, down 2.68% on the day. Prices are delayed at least 15 minutes.
Who is Co-Diagnostics's CEO?
Mr. Dwight H. Egan is the chief executive officer of Co-Diagnostics Inc., which has about 115 employees.
What is the CODX 52-week high?
The 52-week high for CODX is $46.50 and the 52-week low is $0.906. The stock is currently 97.7% below its high.